Literature DB >> 10367733

Neurite outgrowth promotion by the alternatively spliced region of tenascin-C is influenced by cell-type specific binding.

S Meiners1, E M Powell, H M Geller.   

Abstract

We have investigated the impact of cellular environment on the neurite outgrowth promoting properties of the alternatively spliced fibronectin type-III region (fnA-D) of tenascin-C. FnA-D promoted neurite outgrowth in vitro when bound to the surface of BHK cells or cerebral cortical astrocytes, but the absolute increase was greater on astrocytes. In addition, different neurite outgrowth promoting sites were revealed within fnA-D bound to the two cellular substrates. FnA-D also promoted neurite outgrowth as a soluble ligand; however, the actions of soluble fnA-D were not affected by cell type. Therefore, we hypothesized that different mechanisms of cellular binding can alter the growth promoting actions of bound fnA-D. We found that fnA-D utilizes two distinct sequences to bind to the BHK cell surface as opposed to the BHK extracellular matrix. In contrast, only one of these sequences is utilized to bind to the astrocyte matrix as opposed to the astrocyte surface. Furthermore, Scatchard analysis indicated two types of receptors for fnA-D on BHK cells and only one type on astrocytes. These results suggest that active sites for neurite outgrowth within fnA-D are differentially revealed depending on cell-specific fnA-D binding sites. Therefore, the function of tenascin-C and its various domains must be considered in terms of cellular context.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367733     DOI: 10.1016/s0945-053x(98)00008-0

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  10 in total

1.  Identification of a neurite outgrowth-promoting motif within the alternatively spliced region of human tenascin-C.

Authors:  S Meiners; M S Nur-e-Kamal; M L Mercado
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 2.  Functional peptide sequences derived from extracellular matrix glycoproteins and their receptors: strategies to improve neuronal regeneration.

Authors:  Sally Meiners; Mary Lynn T Mercado
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 3.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

4.  Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance.

Authors:  S Meiners; M L Mercado; M S Nur-e-Kamal; H M Geller
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

5.  Myosin II activity regulates neurite outgrowth and guidance in response to chondroitin sulfate proteoglycans.

Authors:  Panpan Yu; Lizzie Y Santiago; Yasuhiro Katagiri; Herbert M Geller
Journal:  J Neurochem       Date:  2012-02-06       Impact factor: 5.372

6.  Different forms of tenascin-C with tenascin-R regulate neural differentiation in bone marrow-derived human mesenchymal stem cells.

Authors:  Hung-Li Tsai; Wen-Ta Chiu; Chia-Lang Fang; Shiaw-Min Hwang; Perry F Renshaw; Wen-Fu Thomas Lai
Journal:  Tissue Eng Part A       Date:  2014-07       Impact factor: 3.845

Review 7.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

Review 8.  The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 9.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 10.  Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease.

Authors:  Emma V Jones; David S Bouvier
Journal:  Neural Plast       Date:  2014-01-16       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.